Eagle Meds Services
Turalio (pexidartinib hydrochloride)
Available to sourceHuman Prescription DrugOncology & Specialty

Turalio (pexidartinib hydrochloride)

125 mg/1 · Capsule
By Daiichi Sankyo Inc.
NDC
65597-407
Route
Oral
Therapeutic class
Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor , Kinase Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 1 BOTTLE in 1 CARTON (65597-407-20) / 120 CAPSULE in 1 BOTTLENDC 65597-407-20Available to order
  • 1 BOTTLE in 1 CARTON (65597-407-28) / 28 CAPSULE in 1 BOTTLENDC 65597-407-28Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Turalio (pexidartinib hydrochloride)
NDC 65597-407